The Eye Cancer Foundation Inc (EIN 134015076) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Phone

2128327297

Tax Period

2023-01-01 to 2023-12-31

The Eye Cancer Foundation Inc, founded in 1998, is a small nonprofit in the Diseases & Disorders sector that reported $333K in total revenue in fiscal year 2023. Revenue decreased 10% compared to the prior year. The organization ran a surplus of $125K, a strong 38% operating margin.

Mission

The Foundation is Committed to Providing a Comprehensive Bio-Psycho-Social Perspective of Care for Person Diagnosed with Ocular Tumors, Macular Degeneration, and Other Major Ophthalmic Disorders. This is Achieved through Educational and Support Services

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $228,757

Program Service Revenue $0

Investment Income $104,110

Other Revenue $0

TOTAL REVENUE $332,867

Expense Breakdown

Grants Paid $0

Salaries & Benefits $74,067

Fundraising Expenses $0

Program Expenses $178,910

Other Expenses $133,327

TOTAL EXPENSES $207,394

Year-over-Year Comparison

	2023	2022	Change
Revenue	$332,867	$369,478	-0.1%
Expenses	$207,394	$150,883	+0.4%
Net Income	$125,473	$218,595	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Dr Paul Finger	Chairman	Officer Director	$0	$0	$0
Myrna Daniels	Vice President	Officer Director	$0	$0	$0
Jack B Friedman ESQ	Secretary	Officer Director	$0	$0	$0
Anne-Marie Montijo	Director	Director	$0	$0	$0
Maureen De Voe	Director	Director	$0	$0	$0
Robert Sauerhaft	Director	Director	$0	$0	$0
Beverly Sommer	Trustee	Director	$0	$0	$0
Marci Finger	Treasurer	Officer Director	$0	$0	$0
Scott Weiner	Director	Director	$0	$0	$0
Lynne Shevlin	Director	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$332,867	$207,394	$2,712,929	$125,473
2022	$369,478	$150,883	$2,536,632	$218,595
2022	No data	No data	No data	No data
2021	$446,658	$226,157	$2,454,185	$220,501
2020	$274,174	$414,744	$2,233,651	$-140,570
2019	$209,349	$131,762	$2,156,290	$77,587
2018	$276,103	$158,776	$1,828,166	$117,327

The Eye Cancer Foundation Inc